Page 337 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 337

CHaPtEr 21  The Human Complement System: Basic Concepts and Clinical Relevance                     317


           55.  Riley-Vargas RC, Lanzendorf S, Atkinson JP. Targeted and restricted   63.  Avery RL. The plague and macular degeneration. Ophthalmology
             complement activation on acrosome-reacted spermatozoa. J Clin Invest   2010;117:2442.
             2005;115:1241–9.                                     64.  Ferreira VP, Pangburn MK, Cortes C. Complement control protein factor
           56.  Sjoholm AG, Jonsson G, Braconier JH, et al. Complement deficiency and   H: the good, the bad, and the inadequate. Mol Immunol
             disease: an update. Mol Immunol 2006;43:78–85.         2010;47:2187–97.
           57.  Bryan AR, Wu EY. Complement deficiencies in systemic lupus   65.  Makou E, Herbert AP, Barlow PN. Functional anatomy of complement
             erythematosus. Curr Allergy Asthma Rep 2014;14:448.    factor H. Biochemistry Mosc 2013;2:3949–62.
           58.  Atkinson JP, Yu CY. The complement system in systemic lupus   66.  Mayilyan KR. Complement genetics, deficiencies, and disease associations.
             erythematosus. In: Tsokos GC, editor. Systemic Lupus Erythematosus,   Protein Cell 2012;3:487–96.
             Basic, Applied and Clinical Aspects. 2016. p. 81–112.  67.  Sturfelt G, Truedsson L. Complement in the immunopathogenesis of
           59.  Wen L, Atkinson JP, Giclas PC. Clinical and laboratory evaluation of   rheumatic disease. Nat Rev Rheumatol 2012;8:458–68.
             complement deficiency. J Allergy Clin Immunol 2004;113:585–93.  68.  Ballanti E, Perricone C, Greco E, et al. Complement and autoimmunity.
           60.  Slade C, Bosco J, Unglik G, et al. Deficiency in complement factor B. N   Immunol Res 2013;56:477–91.
             Engl J Med 2013;369:1667–9.                          69.  Sekar A, Bialas AR, de Rivera H, et al. Schizophrenia risk from complex
           61.  Seelen MA, Roos A, Daha MR. Role of complement in innate and   variation of complement component 4. Nature 2016;530:177–83.
             autoimmunity. J Nephrol 2005;18:642–53.              70.  Morgan BP, Harris CL. Complement, a target for therapy in inflammatory
           62.  Reis E, Falcao DA, Isaac L. Clinical aspects and molecular basis of   and degenerative diseases. Nat Rev Drug Discov 2015;14:857–77.
             primary deficiencies of complement component C3 and its regulatory
             proteins factor I and factor H. Scand J Immunol 2006;63:155–68.
   332   333   334   335   336   337   338   339   340   341   342